IDEX Biometrics Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de IDEX Biometrics.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Electronic	18.8%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	11 Aug 2023

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Chief Executive Officer Vincent Graziani Just Bought 19% More Shares In IDEX Biometrics ASA (OB:IDEX)

Mar 03

Did The Underlying Business Drive IDEX Biometrics' (OB:IDEX) Lovely 324% Share Price Gain?

Feb 27

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como IDEX Biometrics no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

OB:IDEX - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2024	45	-5	N/A	N/A	1
3/31/2024	3	-25	-25	-25	N/A
12/31/2023	4	-27	-27	-27	N/A
9/30/2023	5	-28	-30	-30	N/A
6/30/2023	5	-30	-30	-30	N/A
3/31/2023	4	-32	-32	-32	N/A
12/31/2022	4	-33	-32	-31	N/A
9/30/2022	4	-37	-33	-32	N/A
6/30/2022	4	-35	-32	-31	N/A
3/31/2022	3	-33	-29	-29	N/A
12/31/2021	3	-33	-28	-28	N/A
9/30/2021	3	-29	-27	-26	N/A
6/30/2021	2	-29	-26	-26	N/A
3/31/2021	2	-28	-25	-25	N/A
12/31/2020	1	-27	-24	-23	N/A
9/30/2020	1	-29	-23	-23	N/A
6/30/2020	0	-30	-24	-23	N/A
3/31/2020	0	-31	-25	-24	N/A
12/31/2019	0	-32	-28	-27	N/A
9/30/2019	0	-30	-28	-27	N/A
6/30/2019	0	-30	-28	-27	N/A
3/31/2019	0	-30	-27	-26	N/A
12/31/2018	0	-30	-28	-27	N/A
9/30/2018	1	-30	-28	-27	N/A
6/30/2018	1	-31	-29	-28	N/A
3/31/2018	2	-32	-33	-33	N/A
12/31/2017	2	-31	N/A	-29	N/A
9/30/2017	3	-30	N/A	-29	N/A
6/30/2017	4	-28	N/A	-25	N/A
3/31/2017	5	-24	N/A	-22	N/A
12/31/2016	4	-24	N/A	-27	N/A
9/30/2016	3	-29	N/A	-28	N/A
6/30/2016	2	-27	N/A	-30	N/A
3/31/2016	0	-28	N/A	-26	N/A
12/31/2015	0	-26	N/A	-21	N/A
9/30/2015	0	-23	N/A	-19	N/A
6/30/2015	0	-21	N/A	-16	N/A
3/31/2015	0	-18	N/A	-19	N/A
12/31/2014	0	-16	N/A	-14	N/A
9/30/2014	0	-16	N/A	-17	N/A
6/30/2014	0	-16	N/A	-13	N/A
3/31/2014	0	-14	N/A	-6	N/A
12/31/2013	0	-11	N/A	-6	N/A
9/30/2013	1	-8	N/A	-4	N/A
6/30/2013	1	-6	N/A	-4	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de IDEX es superior a la tasa de ahorro (2%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de IDEX crezcan más rápidamente que el mercado Norwegian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de IDEX crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de IDEX crezcan más rápidamente que el mercado de Norwegian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de IDEX crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de IDEX se prevé que sea elevada dentro de 3 años.

IDEX Biometrics Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Forecast to breakeven in 2024

IDEX Biometrics ASA Provides Revenue Guidance for the Second Half of 2022

Forecast to breakeven in 2024

IDEX Biometrics ASA Provides Revenue Guidance for the Fourth Quarter of 2021

Recent updates

IDEX Biometrics ASA Appoints Morten Opstad as Chair

IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 55 million.

IDEX Biometrics ASA has filed a Follow-on Equity Offering.

IDEX Biometrics ASA, Annual General Meeting, May 16, 2024

IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 35 million.

IDEX Biometrics ASA announced that it expects to receive NOK 100 million in funding

IDEX Biometrics ASA Announces Chief Financial Officer Changes

IDEX Biometrics Payment Card Solution Fully Certified by Mastercard

IDEX Biometrics Announces Intention to Voluntary Delist of American Depositary Shares from the Nasdaq Capital Market

IDEX Biometrics ASA announced that it expects to receive NOK 150 million in funding

IDEX Biometrics ASA Approves the Election of Adriana Saitta as Board Member

IDEX Biometrics Launches a Complete Biometric Payment Card Solution Leveraging Products and Technologies from STMicroelectronics

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Full year 2022 earnings: EPS and revenues exceed analyst expectations

IDEX Biometrics ASA, Annual General Meeting, May 11, 2023

Third quarter 2022 earnings released: US$0.009 loss per share (vs US$0.008 loss in 3Q 2021)

Third quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 3Q 2021)

Forecast to breakeven in 2024

Here's Why IDEX Biometrics (OB:IDEX) Must Use Its Cash Wisely

IDEX Biometrics ASA Provides Revenue Guidance for the Second Half of 2022

Second quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 2Q 2021)

IDEX Biometrics Announces CFO Transition, Effective August 15, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Forecast to breakeven in 2024

Third quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 3Q 2020)

We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth Carefully

Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 2Q 2020)

IDEX Biometrics ASA Biometrics Announces Trustedbio Max

We Think IDEX Biometrics (OB:IDEX) Needs To Drive Business Growth Carefully

First quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2020)

IDEX Biometrics ASA Provides Revenue Guidance for the Fourth Quarter of 2021

Advisor has left the company

Full year 2020 earnings released: US$0.035 loss per share (vs US$0.054 loss in FY 2019)

IDEX Biometrics Further Strengthens its Supply Chain by Partnering with MFLEX

Chief Executive Officer Vincent Graziani Just Bought 19% More Shares In IDEX Biometrics ASA (OB:IDEX)

Chief Executive Officer recently bought kr37m worth of stock

Did The Underlying Business Drive IDEX Biometrics' (OB:IDEX) Lovely 324% Share Price Gain?

Full year 2020 earnings released: US$0.03 loss per share (vs US$0.055 loss in FY 2019)

Revenue and earnings miss expectations

New 90-day high: kr3.33

Postal Savings Bank of China Launches Idex's Fingerprint Sensors and Biometric Software Have Been Included in Digital RMB

China UnionPay Awards Second LOA to Biometric Payment Card Featuring IDEX Biometrics’ Fingerprint Sensor & Biometric Technology

IDEX Biometrics ASA Expands Partnership with Global Payment Solutions Provider to Include Joint Marketing and Sales

IDEX Biometrics ASA & Tongxin Microelectronics’ Co., Ltd Collaboration Achieves Second China UnionPay Certification

IDEX Biometrics ASA Expands its Strategic Partnerships by Adding Another Global Payment Network

IDEX Biometrics ASA and Partner Goldpac Group Limited Achieve China Union Pay Certification for Dual Interface Biometric Payment Cards

New 90-day high: kr3.10

IDEX Biometrics ASA to Report Q1, 2021 Results on May 13, 2021

New 90-day high: kr2.67

IDEX Biometrics ASA announced that it has received NOK 70.125 million in funding

IDEX Biometrics Receives Volume Production Orders for Current and Next Generation Fingerprint Sensors from Dongwoon Anatech

Thomas M. Quindlen Joins the Board of IDEX Biometrics

Ubivelox Selects IDEX Biometrics TrustedBio™ Fingerprint Sensors and Biometric Solutions

New 90-day high: kr2.49

New 90-day high - kr1.77

Chief Executive Officer recently bought kr578k worth of stock

Earnings released

New 90-day high - kr1.76

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento